MLH1 tends to have an insignificant impact on the survival of patients with other cancers (Supplemental Figure, 3 G–J and L–O), supporting a tissue-specific role of MLH1 in BRCA2-associated breast cancer. Here, BRCA2 is linked to breast carcinoma.